Molnupiravir can be used for high-risk Covid patients: WHO

WHO recommends Merck’s COVID pill for high-risk patients

(Reuters) – A World Health Organization (WHO) panel on Wednesday backed the use of Merck & Co Inc’s COVID-19 antiviral pill for high-risk patients.The expert panel conditionally recommended the pill, molnupiravir, for patients with non-severe disease who are at high risk of hospitalisation, such as the immunocompromised, the unvaccinated, older people and those with chronic diseases.The recommendation was based on new data from six clinical tria…

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.

WHO recommends Merck's new oral corona drug for high-risk patients

[Reuters] --On the 2nd, the World Health Organization (WHO) expert committee recommended the use of the new coronavirus infectious disease oral drug "Mornupiravir" by the major US pharmaceutical company Merck for high-risk patients. Conditionally recommended for use in non-severe patients at high risk of hospitalization. People with immune disorders, unvaccinated people, the elderly, people with chronic diseases, etc. are targeted. The expert co…

WHO Recommends Covid Pill Molnupiravir for High-risk Patients as Controlled Trials Bring Hope

The WHO has however warned against using the drug on young and healthy patients, including children, and pregnant and breastfeeding women.

WHO recommends Merck COVID pill for non-severe, at-risk patients

The World Health Organization on Wednesday recommended an anti-COVID pill be taken by sufferers who have mild symptoms but are at high risk of hospitalization, such as older people or the unvaccinated.

WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients

The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.